Cancer treatment: from traditional Chinese herbal medicine to the liposome delivery system
Authors:
Open Access
- 14 December 2022
- journal article
- review article
- Published by Compuscript, Ltd. in Acta Materia Medica
- Vol. 1 (4)
Abstract
Traditional Chinese herbal (TCH) medicines have emerged as a prospective and affordable method to treat various diseases with a broad range of biological activity; however, traditional preparations, like decoctions, are often associated with low bioavailability, thus resulting in limited efficacy against cancer. The drawbacks of active TCH components, including instability, poor permeability, high hydrophilicity or hydrophobicity, undesirable pharmacokinetic profiles, and off-target toxicity, also exist. Most TCH medicines are thus limited to a clinical alternative for the treatment of chronic diseases. A liposomal delivery system is the most common class of FDA-approved nanomedicines, which has improved pharmacokinetics, enhanced targetability, and reduced side effects. Therefore, we anticipate that liposomal delivery technology will help concentrate drugs inside tumors, and fully release the therapeutic potential and reduce the side effects of TCH medicines. The review provides a brief overview of several representative TCH components and related liposome delivery strategies for enhanced cancer therapy. Current challenges associated with liposomal targeting of TCH medicines are also discussed for interested researchers.Keywords
This publication has 127 references indexed in Scilit:
- Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancerCancer Letters, 2013
- Nanoprobes Visualizing Gliomas by Crossing the Blood Brain Tumor BarrierSmall, 2013
- Targeted Delivery of Nano-Therapeutics for Major Disorders of the Central Nervous SystemPharmaceutical Research, 2013
- Endosomal escape pathways for delivery of biologicalsJournal of Controlled Release, 2011
- Breast cancer surgery‐induced immunomodulationJournal of Surgical Oncology, 2010
- Ginsenoside Rh2-mediated G1 Phase Cell Cycle Arrest in Human Breast Cancer Cells Is Caused by p15 Ink4B and p27 Kip1 -dependent Inhibition of Cyclin-dependent KinasesPharmaceutical Research, 2009
- Stromal MCP‐1 in mammary tumors induces tumor‐associated macrophage infiltration and contributes to tumor progressionInternational Journal of Cancer, 2009
- Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP‐1 and NFκB transcription factorsJournal of Neurochemistry, 2007
- Curcumin enhances Vinorelbine mediated apoptosis in NSCLC cells by the mitochondrial pathwayBiochemical and Biophysical Research Communications, 2005
- Differential suppression by tripterygium wilfordii extracts (traditional chinese medicine) in the allogeneic rat mixed lymphocyte reactionTransplantation Proceedings, 2000